SDB-006

From Wikipedia, the free encyclopedia
Jump to: navigation, search
SDB-006
SDB-006 structure.png
Systematic (IUPAC) name
N-benzyl-1-pentyl-1H-indole-3-carboxamide
Clinical data
Identifiers
695213-59-3 YesY
PubChem CID 2227769
Chemical data
Formula C21H24N2O
320.43 g/mol

SDB-006 is a drug that acts as a potent agonist for the cannabinoid receptors, with an EC50 for CB1 activation of 19nM, and 7x selectivity for CB1 over CB2. It was discovered during research into the related compound SDB-001 which had been sold illicitly as "2NE1".[1]


See also[edit]


References[edit]

  1. ^ Banister, S. D.; Wilkinson, S. M.; Longworth, M.; Stuart, J.; Apetz, N.; English, K.; Brooker, L.; Goebel, C.; Hibbs, D. E.; Glass, M.; Connor, M.; McGregor, I. S.; Kassiou, M. (2013). "The synthesis and pharmacological evaluation of adamantane-derived indoles: Novel cannabimimetic drugs of abuse". ACS Chemical Neuroscience 4 (7): 130403084729007. doi:10.1021/cn400035r.  edit